What is Beep Saúde?
Founded in 2016 and headquartered in Rio de Janeiro, Brazil, Beep Saúde operates a unique mobile-first platform that facilitates convenient in-home vaccination services. Users can easily order vaccines and schedule appointments with healthcare professionals through its dedicated app. This approach addresses a critical need for accessible healthcare, particularly for routine immunizations, positioning Beep Saúde as a disruptive force in the Brazilian healthcare market.
How much funding has Beep Saúde raised?
Beep Saúde has raised a total of $22.9M across 2 funding rounds:
Series A
$3.3M
Series B
$19.6M
Series A (2020): $3.3M with participation from DNA Capital and InovaBRA
Series B (2021): $19.6M led by Endeavor Global, DNA Capital, David Velez, VALUE CAPITAL GROUP, and Bradesco
Key Investors in Beep Saúde
Endeavor Global
Endeavor Global is an organization focused on supporting entrepreneurs with significant economic and social impact potential, providing resources to help ventures grow and create jobs.
DNA Capital
DNA Capital is an investment and business banking firm specializing in mergers, acquisitions, and capital raising, with a focus on supporting seasoned management teams and accredited investors.
David Velez
An individual investor who participated in the Series B funding round.
What's next for Beep Saúde?
The substantial enterprise-level funding, particularly the recent strategic investment, positions Beep Saúde for accelerated expansion and service enhancement. This capital is likely to be deployed towards scaling its operational footprint across Brazil, enhancing its technological infrastructure, and potentially broadening its service offerings. The company's focus on convenience and accessibility in healthcare delivery suggests a continued emphasis on leveraging technology to improve patient outcomes and market penetration. Future growth may involve strategic partnerships and further innovation in mobile health solutions.
See full Beep Saúde company page
